Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
8
×
medicare
8
×
national blog main
startups
8
×
life sciences
national top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
eli lilly
alzheimer's disease
biogen
cancer
cancer immunotherapy
clinical trials
drug prices
novartis
abbvie
amgen
What
bio
roundup
drug
alzheimer’s
companies
company
health
healthcare
million
pharmaceutical
price
prices
acquisitions
advance
albert
andreessen
announced
annual
answer
appetite
approach
approval
assessed
attention
big
bigger
biggest
biogen’s
biopharmaceutical
biotech
black
boston
bourla
bread
butter
buyout
called
cancer
cash
ceo
Language
unknown
Current search:
medicare
×
startups
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Iora Health Goes Big With $100M to Advance Collaborative Care Model